Lucid Diagnostics LUCD EPS (Diluted)
Discontinued — last reported Q3 '25
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Lucid Diagnostics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Lucid Diagnostics’s 10-Q, filed November 12, 2025, on SEC EDGAR. View the filing →
Ask your AI about Lucid Diagnostics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lucid Diagnostics's EPS (diluted)?
- Lucid Diagnostics (LUCD) reported EPS (diluted) of -$0.10 in Q3 2025.
- How has Lucid Diagnostics's EPS (diluted) changed year-over-year?
- Lucid Diagnostics's EPS (diluted) increased by 60.0% year-over-year, from -$0.25 to -$0.10.
- What is the long-term trend for Lucid Diagnostics's EPS (diluted)?
- Over 2 years (2022 to 2024), Lucid Diagnostics's EPS (diluted) has grown at a -17.3% compound annual growth rate (CAGR), from -$1.55 to -$1.06.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.